無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

免疫組織化学 (IHC) の世界市場:2022年

Immunohistochemistry (IHC): Global Markets to 2022

発行 BCC Research 商品コード 660267
出版日 ページ情報 英文 184 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.33円で換算しております。
Back to Top
免疫組織化学 (IHC) の世界市場:2022年 Immunohistochemistry (IHC): Global Markets to 2022
出版日: 2018年07月03日 ページ情報: 英文 184 Pages
概要

世界の免疫組織化学 (IHC) 市場規模は、2017年に16億米ドルとなり、2017年から2022年の期間中は7.8%のCAGR (年間複合成長率) で推移し、2022年までに23億米ドルに達すると予測されています。

当レポートでは、世界の免疫組織化学 (IHC) 市場を調査し、世界市場の概要と消費予測、世界市場の動向、主要動向、課題、サプライヤー情勢、エンドユーズ産業、市場ダイナミクス、および主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 市場・技術背景

  • 免疫組織化学 (IHC) の歴史
  • 免疫組織化学 (IHC) 市場の規制・規格
  • 免疫組織化学 (IHC) 市場における装置
  • 免疫組織化学 (IHC) 市場における試薬
  • 免疫組織化学 (IHC) 市場における抗体
  • 区分:製品別
  • 区分:用途別
  • 区分:エンドユーザー別
  • 区分:地域別

第4章 市場分析:製品別

  • 抗体
  • 装置
  • 試薬
  • キット

第5章 市場分析:用途別

  • 診断
  • 薬物検査

第6章 市場分析:エンドユーザー別

  • 病院・診断ラボ
  • 研究機関
  • その他

第7章 市場分析:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第8章 市場成長の促進要因

  • 影響分析

第9章 企業プロファイル・ベンダー情勢

第10章 BBC Reserchについて

図表

List of Tables

  • Summary Table: Global Immunohistochemistry Market, by Product, Through 2022
    • Table 1: Immunohistochemistry Laboratory Standards and Regulations
    • Table 2: U.S. Centers for Disease Control Biosafety Regulations
    • Table 3: Antibody Manufacturers and Products Available in the Global Immunohistochemistry Market
    • Table 4: Global Immunohistochemistry Market, by Product, Through 2022
    • Table 5: Global Immunohistochemistry Market, by Antibodies, Through 2022
    • Table 6: Diabetes Incidence in the Top 10 Countries, 2016
    • Table 7: Global Antibodies Market, by Region, Through 2022
    • Table 8: Global Primary Antibodies Market, by Region, Through 2022
    • Table 9: Examples of Clinically Important Monoclonal Antibodies
    • Table 10: Secondary Antibody Selection
    • Table 11: Global Secondary Antibodies Market, by Region, Through 2022
    • Table 12: Global Immunohistochemistry Market, by Equipment, Through 2022
    • Table 13: Global Immunohistochemistry Equipment Market, by Region, Through 2022
    • Table 14: Global Slide Staining Systems Market, by Region, Through 2022
    • Table 15: Estimated Number of U.S. Cancer Survivors, by Sex and Survival Years, as of Jan. 1, 2016
    • Table 16: Global Tissue Microarrays Market, by Region, Through 2022
    • Table 17: Healthcare Spending by Different Income Level Countries, 2040
    • Table 18: Global Tissue Processing Systems Market, by Region, Through 2022
    • Table 19: Global Slide Scanners Market, by Region, Through 2022
    • Table 20: Global Other Equipment Market, by Region, Through 2022
    • Table 21: Global Immunohistochemistry Market, by Reagent, Through 2022
    • Table 22: Global Reagents Market, by Region, Through 2022
    • Table 23: Global Histological Stains Market, by Region, Through 2022
    • Table 24: Categories of Histological Stains
    • Table 25: Global Blocking Sera and Reagents Market, by Region, Through 2022
    • Table 26: Global Chromogenic Substrates Market, by Region, Through 2022
    • Table 27: Global Fixation Reagents Market, by Region, Through 2022
    • Table 28: Most Common Fixatives and Their General Target Antigens
    • Table 29: Global Stabilizers Market, by Region, Through 2022
    • Table 30: The Most Common Causes of Cancer Death, 2015
    • Table 31: Global Organic Solvents Market, by Region, Through 2022
    • Table 32: Global Proteolytic Enzymes Market, by Region, Through 2022
    • Table 33: Global Diluents Market, by Region, Through 2022
    • Table 34: Kit Components for Immunohistochemistry Optimization
    • Table 35: Global IHC Kits Market, by Region, Through 2022
    • Table 36: Global Immunohistochemistry Market, by Application, Through 2022
    • Table 37: Global Immunohistochemistry Diagnostics Market, by Application, Through 2022
    • Table 38: Global Immunohistochemistry Diagnostics Market, by Region, Through 2022
    • Table 39: Global Cancer Diagnostics Market, by Region, Through 2022
    • Table 40: Global Immunohistochemistry Infectious Disease Applications Market, by Region, Through 2022
    • Table 41: Global Immunohistochemistry Cardiovascular Disease Applications Market, by Region, Through 2022
    • Table 42: Selected Infectious Etiologies of Autoimmune Diseases
    • Table 43: Global Immunohistochemistry Autoimmune Disease Applications Market, by Region, Through 2022
    • Table 44: Diabetes Incidence in the Top 10 Countries, 2016
    • Table 45: Global Immunohistochemistry Diabetes Mellitus Applications Market, by Region, Through 2022
    • Table 46: Global Immunohistochemistry Nephrological Disease Applications Market, by Region, Through 2022
    • Table 47: Global Immunohistochemistry Drug Testing Applications Market, by Region, Through 2022
    • Table 48: Global Immunohistochemistry Market, by End User, Through 2022
    • Table 49: Global Immunohistochemistry Hospital and Diagnostic Laboratory Applications Market, by Region, Through 2022
    • Table 50: Various Cancer Research Studies
    • Table 51: Global Immunohistochemistry Research Institute Applications Market, by Region, Through 2022
    • Table 52: Uses of Immunohistochemistry in Forensic Pathology
    • Table 53: Global Immunohistochemistry Other End User Applications Market, by Region, Through 2022
    • Table 54: Global Immunohistochemistry Market, by Region, Through 2022
    • Table 55: Grants by Type of Cancer, 2017
    • Table 56: Estimated New Cancer Cases in Males in Canada, 2017
    • Table 57: Estimated New Cancer Cases in Females in Canada, 2017
    • Table 58: Deaths from CVD and Number of People Living with CVD in the U.K., 2017
    • Table 59: Death Rate Due to Cardiovascular Diseases in the U.K., 2017
    • Table 60: Deaths Caused by Cardiovascular Disease Compared with Other Causes of Death in Germany, 2016
    • Table 61: Diseases Causing the Greatest Number of Premature Deaths in Germany, Percentage Change from 2005-2016
    • Table 62: Cancer Incidence Rates in Asia-Pacific, 2016
    • Table 63: Mortality Rates in Asia-Pacific, by Cancer Type, 2016
    • Table 64: Top Five Types Cancer in Men and Women in India, 2017
    • Table 65: Estimated Incidence of All Cancers in Australia, by Sex, 2017
    • Table 66: Estimated 20 Most Commonly Diagnosed Cancers in Males in Australia, 2017
    • Table 67: Estimated 20 Most Commonly Diagnosed Cancers in Females in Australia, 2017
    • Table 68: 10 Most Common Cancers in Australia Considering Principal Diagnosis, 2014-2015 (Number/%)
    • Table 69: Estimated 10 Most Common Causes of Death from Cancer in Males in Australia, 2017
    • Table 70: Estimated 10 Most Common Causes of Death from Cancer in Females in Australia, 2017
    • Table 71: Percentage of Population in Brazil, Age 60 and Above
    • Table 72: Top 10 Causes of Death in Mexico and Percentage Increase from 2005-2016
    • Table 73: Top 10 Causes of Death in Argentina and Percentage Change, 2005-2016
    • Table 74: Top 10 Causes of Death in Cuba and Percentage Change, 2005-2016
    • Table 75: Impact Analysis of Market Drivers
    • Table 76: Cancer Markers Used in the Diagnosis and Treatment of Different Types of Cancer
    • Table 77: Global Population Aged 60 Years and Above, by Region
    • Table 78: Global Population Aged 80 Years and Above, by Region
    • Table 79: Countries with the Highest Elderly Populations, 2015 and 2030
    • Table 80: Abbott Laboratories: Product Portfolio
    • Table 81: Abcam: Product Portfolio
    • Table 82: Abcam Recent Developments, 2015-2018
    • Table 83: Abnova: Product Portfolio
    • Table 84: Agilent Technologies Inc.: Product Portfolio
    • Table 85: Agilent Technologies Inc. Recent Developments, 2015-2018
    • Table 86: Arrayit Corp.: Product Portfolio
    • Table 87: Arrayit Corp. Recent Developments, 2015-2018
    • Table 88: Bio SB: Product Portfolio
    • Table 89: Bio SB Recent Developments, 2015-2018
    • Table 90: Biocare Medical: Product Portfolio
    • Table 91: Biocare Medical Recent Developments, 2015-2018
    • Table 92: Biogenex: Product Portfolio
    • Table 93: Biogenex Recent Developments, 2015-2018
    • Table 94: BioLegend: Product Portfolio
    • Table 95: Bio-Rad Laboratories Inc.: Product Portfolio
    • Table 96: Candor Bioscience Gmbh: Product Portfolio
    • Table 97: Cell Marque Corp.: Product Portfolio
    • Table 98: Cell Signaling Technology Inc.: Product Portfolio
    • Table 99: Cell Signaling Technology Inc.Recent Developments, 2015-2018
    • Table 100: Danaher Corp.: Product Portfolio
    • Table 101: Danaher Corp. Recent Developments, 2015-2018
    • Table 102: Diagnostic Biosystems Inc.: Product Portfolio
    • Table 103: F. Hoffmann-La Roche Ag: Product Portfolio
    • Table 104: F. Hoffmann-La Roche Ag Recent Developments, 2015-2018
    • Table 105: Histologix: Product Portfolio
    • Table 106: Immunologic: Product Portfolio
    • Table 107: LSBio: Product Portfolio
    • Table 108: Merck Millipore: Product Portfolio
    • Table 109: Novodiax: Product Portfolio
    • Table 110: Novodiax Recent Developments, 2015-2018
    • Table 111: PeproTech Gmbh: Product Portfolio
    • Table 112: Perkinelmer Inc.: Product Portfolio
    • Table 113: Rockland Immunochemicals: Product Portfolio
    • Table 114: Sakura Finetek Usa Inc.: Product Portfolio
    • Table 115: Sakura Finetek Usa Inc. Recent Developments, 2015-2018
    • Table 116: Siemens AG Healthcare: Product Portfolio
    • Table 117: Thermo Fisher Scientific Inc.: Product Portfolio
    • Table 118: Thermo Fisher Scientific Inc. Recent Developments, 2015-2018
    • Table 119: Vector Laboratories: Product Portfolio
    • Table 120: Vector Laboratories Recent Developments, 2015-2018

List of Figures

  • Summary Figure: Global Market for Immunohistochemistry, by Product, 2016-2022
    • Figure 1: Outline of The Steps Needed to Localize Antigens in IHC Testing
    • Figure 2: Immunohistochemistry Timeline
    • Figure 3: Immunohistochemistry Test Procedure
    • Figure 4: Global Immunohistochemistry Market Shares, by Product, 2016 and 2022
    • Figure 5: Phases of Histological Staining
    • Figure 6: Global Immunohistochemistry Market Shares, by Application, 2016 and 2022
    • Figure 7: Global Immunohistochemistry Market Shares, by End User, 2016 and 2022
    • Figure 8: Global Immunohistochemistry Market Shares, by Region, 2016 and 2022
    • Figure 9: Global Immunohistochemistry Market Shares, by Product, 2016 and 2022
    • Figure 10: Number of Cancer Cases Worldwide, 2012 and 2030
    • Figure 11: Number of People with Chronic Conditions in the United States, 2010-2025
    • Figure 12: Percentage Distribution of Population Aged 65 and Over, by Region, 2015 and 2050
    • Figure 13: Global Immunohistochemistry Market Share, by Service, 2016
    • Figure 14: Number of New TB Cases, 2016
    • Figure 15: New HIV Diagnoses in the United States, by Age, 2016
    • Figure 16: Estimated Number of Colon Cancer Cases in the U.S, 2017 and 2018
    • Figure 17: Global Immunohistochemistry Market Shares, by Application, 2016 and 2022
    • Figure 18: Global Prevalence of Colon Cancer, by Age, 2016
    • Figure 19: New Global HIV Infections, by Region, 2016
    • Figure 20: Healthcare Expenditures Across the Globe, 2014-2016
    • Figure 21: Healthcare Cost Comparison of Autoimmune Diseases and Cancer, 2015
    • Figure 22: Global Prevalence of Diabetes, by Age Group and Region
    • Figure 23: Global Prevalence of Chronic Kidney Diseases, by Age
    • Figure 24: Global Development of Medicines, by Disease Type
    • Figure 25: Global Share of R&D Spending on Drug Testing, by Region, 2016
    • Figure 26: Global Immunohistochemistry Market Shares, by End User, 2016 and 2022
    • Figure 27: Global Incidence of Patients with Chronic Diseases, 2005-2030
    • Figure 28: New Cases of Cancer in France, 2015
    • Figure 29: Health Spending and Financing in France, 2005-2015
    • Figure 30: Market Demand for Medical Equipment in France
    • Figure 31: Healthcare Spending in Mexico, 2014 and 2040
    • Figure 32: Healthcare Spending in Argentina, 2014 and 2040
    • Figure 33: Healthcare Expenditures and Financing in Chili, 2005-2016
    • Figure 34: Healthcare Spending in Cuba, 2014 and 2040
    • Figure 35: Global GDP Shares of Healthcare Expenditures and Financing, by Country 2010-2016
目次
Product Code: BIO161A

Highlights:

The global immunohistochemistry market totaled $1.6 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 7.8% for the period of 2017-2022.

Antibodies immunohistochemistry market totaled $721.0 million in 2017 and is estimated to reach $1.0 billion by 2022, growing at a CAGR of 7.7% for the period of 2017-2022.

Reagents immunohistochemistry market totaled $362.9 million in 2017 and is estimated to reach $534.2 million by 2022, growing at a CAGR of 8.0% for the period of 2017-2022.

Report Scope:

The scope of this market report is widely characterized by products that include antibodies, equipment, kits and reagents. The total market revenue is restricted to the revenues obtained from the sales of the products required to perform IHC testing successfully. This report covers the different applications of immunohistochemistry in drugs and diagnostics.

Report Includes:

  • 56 data tables and 65 additional tables
  • An overview of the global markets and expected consumption for immunohistochemistry (IHC) technologies
  • Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Coverage of major trends and challenges that affect the market and the supplier landscape
  • End-use industry coverage, including hospitals and diagnostic laboratories, and research institutes
  • Evaluation of the market's dynamics, including growth drivers and restraints
  • Company profiles of major players in the market, including Abbott Laboratories, Abcam, Abnova, Danaher Corp. and PeproTech GmbH

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Definition of Immunohistochemistry
  • Scope of Report
  • Intended Audience
  • Research Methodology and Information Sources
  • Analyst's Credentials
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Market and Technology Background

  • History of Immunohistochemistry
  • Regulations and Standards of the Immunohistochemistry Market
    • U.S. Food and Drug Administration
  • Equipment in the Immunohistochemistry Market
    • Raw Material Suppliers
    • Equipment Manufacturers
    • Distributors
    • End Users
    • Factors Affecting the Immunohistochemistry Equipment Market
    • Reagents in the Immunohistochemistry Market
    • Raw Material Suppliers
    • Reagent Manufacturers
    • Distributors
    • End Users
    • Factors Affecting the Immunohistochemistry Reagent Market
  • Antibodies in the Immunohistochemistry Market
    • Manufacturers of Antibodies Used in the Immunohistochemistry Market
  • Segmentation by Product
    • Antibodies
    • Equipment
    • Reagents
  • Segmentation by Application
    • Diagnostics
    • Drug Testing
  • Segmentation by End User
    • Hospital and Diagnostics Laboratories
    • Research Institutes
    • Other (Contract Research Organization and Forensic Laboratories)
  • Segmentation by Region
    • North America
    • Europe
    • Asia-Pacific
    • South America
    • Rest of the World

Chapter 4: Market Breakdown by Product

  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Equipment
    • Slide Staining Systems
    • Tissue Microarrays
    • Tissue Processing Systems
    • Slide Scanners
    • Other Equipment (Microtome, Water Bath, pH Meter, etc.)
  • Reagents
    • Histological Stains
    • Blocking Sera and Reagents
    • Chromogenic Substrates
    • Fixation Reagents
    • Stabilizers
    • Organic Solvents
    • Proteolytic Enzymes
    • Diluents
  • Kits

Chapter 5: Market Breakdown by Application

  • Diagnostics
    • The Process of Immunohistochemistry in Diagnoses
    • Cancer Diagnostics
    • Infectious Diseases
    • Cardiovascular Disease
    • Autoimmune Diseases
    • Diabetes Mellitus
    • Nephrological Diseases
  • Drug Testing

Chapter 6: Market Breakdown by End User

  • Hospitals and Diagnostic Laboratories
  • Research Institutes
  • Other End Users

Chapter 7: Market Breakdown by Region

  • North America
    • United States
    • Canada
  • Europe
    • United Kingdom
    • France
    • Germany
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Chile
    • Cuba
    • Middle East and Africa

Chapter 8: Market Drivers

  • Impact Analysis
    • Growing Prevalence of Cancer
    • Rapidly Increasing Geriatric Population
    • Rapid Technological Developments in the IVD Industry
    • Increasing Healthcare Spending

Chapter 9: Company Profiles and Vendor Landscape

  • ABBOTT LABORATORIES
  • ABCAM
  • ABNOVA
  • AGILENT TECHNOLOGIES INC.
  • ARRAYIT CORP.
  • BIO SB
  • BIOCARE MEDICAL
  • BIOGENEX
  • BIOLEGEND
  • BIO-RAD LABORATORIES INC.
  • CANDOR BIOSCIENCE GMBH
  • CELL MARQUE CORP.
  • CELL SIGNALING TECHNOLOGY INC.
  • DANAHER CORP.
  • DIAGNOSTIC BIOSYSTEMS INC.
  • F. HOFFMANN-LA ROCHE AG
  • HISTOLOGIX
  • IMMUNOLOGIC
  • LSBIO
  • MERCK MILLIPORE
  • NOVODIAX
  • PEPROTECH GMBH
  • PERKINELMER INC.
  • ROCKLAND IMMUNOCHEMICALS
  • SAKURA FINETEK USA INC.
  • SIEMENS AG HEALTHCARE
  • THERMO FISHER SCIENTIFIC INC.
  • VECTOR LABORATORIES
Back to Top